Literature DB >> 20075864

Coordinated regulation of p53 apoptotic targets BAX and PUMA by SMAR1 through an identical MAR element.

Surajit Sinha1, Sunil Kumar Malonia, Smriti P K Mittal, Kamini Singh, Sreenath Kadreppa, Rohan Kamat, Robin Mukhopadhyaya, Jayanta K Pal, Samit Chattopadhyay.   

Abstract

How tumour suppressor p53 bifurcates cell cycle arrest and apoptosis and executes these distinct pathways is not clearly understood. We show that BAX and PUMA promoters harbour an identical MAR element and are transcriptional targets of SMAR1. On mild DNA damage, SMAR1 selectively represses BAX and PUMA through binding to the MAR independently of inducing p53 deacetylation through HDAC1. This generates an anti-apoptotic response leading to cell cycle arrest. Importantly, knockdown of SMAR1 induces apoptosis, which is abrogated in the absence of p53. Conversely, apoptotic DNA damage results in increased size and number of promyelocytic leukaemia (PML) nuclear bodies with consequent sequestration of SMAR1. This facilitates p53 acetylation and restricts SMAR1 binding to BAX and PUMA MAR leading to apoptosis. Thus, our study establishes MAR as a damage responsive cis element and SMAR1-PML crosstalk as a switch that modulates the decision between cell cycle arrest and apoptosis in response to DNA damage.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20075864      PMCID: PMC2829167          DOI: 10.1038/emboj.2009.395

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  34 in total

1.  MDM2 inhibits p300-mediated p53 acetylation and activation by forming a ternary complex with the two proteins.

Authors:  E Kobet; X Zeng; Y Zhu; D Keller; H Lu
Journal:  Proc Natl Acad Sci U S A       Date:  2000-11-07       Impact factor: 11.205

2.  ASPP proteins specifically stimulate the apoptotic function of p53.

Authors:  Y Samuels-Lev; D J O'Connor; D Bergamaschi; G Trigiante; J K Hsieh; S Zhong; I Campargue; L Naumovski; T Crook; X Lu
Journal:  Mol Cell       Date:  2001-10       Impact factor: 17.970

3.  Directed proteomic analysis of the human nucleolus.

Authors:  Jens S Andersen; Carol E Lyon; Archa H Fox; Anthony K L Leung; Yun Wah Lam; Hanno Steen; Matthias Mann; Angus I Lamond
Journal:  Curr Biol       Date:  2002-01-08       Impact factor: 10.834

4.  p53 binds the nuclear matrix in normal cells: binding involves the proline-rich domain of p53 and increases following genotoxic stress.

Authors:  M Jiang; T Axe; R Holgate; C P Rubbi; A L Okorokov; T Mee; J Milner
Journal:  Oncogene       Date:  2001-09-06       Impact factor: 9.867

5.  The function of PML in p53-dependent apoptosis.

Authors:  A Guo; P Salomoni; J Luo; A Shih; S Zhong; W Gu; P P Pandolfi
Journal:  Nat Cell Biol       Date:  2000-10       Impact factor: 28.824

6.  Acetylation is indispensable for p53 activation.

Authors:  Yi Tang; Wenhui Zhao; Yue Chen; Yingming Zhao; Wei Gu
Journal:  Cell       Date:  2008-05-16       Impact factor: 41.582

7.  Role of SUMO-1-modified PML in nuclear body formation.

Authors:  S Zhong; S Müller; S Ronchetti; P S Freemont; A Dejean; P P Pandolfi
Journal:  Blood       Date:  2000-05-01       Impact factor: 22.113

8.  MDM2-HDAC1-mediated deacetylation of p53 is required for its degradation.

Authors:  Akihiro Ito; Yoshiharu Kawaguchi; Chun-Hsiang Lai; Jeffrey J Kovacs; Yuichiro Higashimoto; Ettore Appella; Tso-Pang Yao
Journal:  EMBO J       Date:  2002-11-15       Impact factor: 11.598

9.  p53AIP1, a potential mediator of p53-dependent apoptosis, and its regulation by Ser-46-phosphorylated p53.

Authors:  K Oda; H Arakawa; T Tanaka; K Matsuda; C Tanikawa; T Mori; H Nishimori; K Tamai; T Tokino; Y Nakamura; Y Taya
Journal:  Cell       Date:  2000-09-15       Impact factor: 41.582

10.  Direct interaction with and activation of p53 by SMAR1 retards cell-cycle progression at G2/M phase and delays tumor growth in mice.

Authors:  Ruchika Kaul; Sujoy Mukherjee; Farid Ahmed; Manoj Kumar Bhat; Rishiraj Chhipa; Sanjeev Galande; Samit Chattopadhyay
Journal:  Int J Cancer       Date:  2003-02-20       Impact factor: 7.396

View more
  31 in total

1.  Reversible induction of translational isoforms of p53 in glucose deprivation.

Authors:  D Khan; A Katoch; A Das; A Sharathchandra; R Lal; P Roy; S Das; S Chattopadhyay; S Das
Journal:  Cell Death Differ       Date:  2015-02-27       Impact factor: 15.828

2.  Curcumin enhances the efficacy of chemotherapy by tailoring p65NFκB-p300 cross-talk in favor of p53-p300 in breast cancer.

Authors:  Gouri Sankar Sen; Suchismita Mohanty; Dewan Md Sakib Hossain; Sankar Bhattacharyya; Shuvomoy Banerjee; Juni Chakraborty; Shilpi Saha; Pallab Ray; Pushpak Bhattacharjee; Debaprasad Mandal; Arindam Bhattacharya; Samit Chattopadhyay; Tanya Das; Gaurisankar Sa
Journal:  J Biol Chem       Date:  2011-10-19       Impact factor: 5.157

Review 3.  APC/C ubiquitin ligase: Functions and mechanisms in tumorigenesis.

Authors:  Morgan S Schrock; Benjamin R Stromberg; Luke Scarberry; Matthew K Summers
Journal:  Semin Cancer Biol       Date:  2020-03-09       Impact factor: 15.707

4.  Late-phase synthesis of IκBα insulates the TLR4-activated canonical NF-κB pathway from noncanonical NF-κB signaling in macrophages.

Authors:  Budhaditya Chatterjee; Balaji Banoth; Tapas Mukherjee; Nandaraj Taye; Bharath Vijayaragavan; Samit Chattopadhyay; James Gomes; Soumen Basak
Journal:  Sci Signal       Date:  2016-12-06       Impact factor: 8.192

5.  Deacetylation of the DNA-binding domain regulates p53-mediated apoptosis.

Authors:  Hestia S Mellert; Timothy J Stanek; Stephen M Sykes; Frank J Rauscher; David C Schultz; Steven B McMahon
Journal:  J Biol Chem       Date:  2010-12-09       Impact factor: 5.157

6.  Nuclear matrix-associated protein SMAR1 regulates alternative splicing via HDAC6-mediated deacetylation of Sam68.

Authors:  Kiran Kumar Nakka; Nidhi Chaudhary; Shruti Joshi; Jyotsna Bhat; Kulwant Singh; Subhrangsu Chatterjee; Renu Malhotra; Abhijit De; Manas Kumar Santra; F Jeffrey Dilworth; Samit Chattopadhyay
Journal:  Proc Natl Acad Sci U S A       Date:  2015-06-15       Impact factor: 11.205

7.  Inhibition of epithelial to mesenchymal transition by E-cadherin up-regulation via repression of slug transcription and inhibition of E-cadherin degradation: dual role of scaffold/matrix attachment region-binding protein 1 (SMAR1) in breast cancer cells.

Authors:  Arghya Adhikary; Samik Chakraborty; Minakshi Mazumdar; Swatilekha Ghosh; Shravanti Mukherjee; Argha Manna; Suchismita Mohanty; Kiran Kumar Nakka; Shruti Joshi; Abhijit De; Samit Chattopadhyay; Gaurisankar Sa; Tanya Das
Journal:  J Biol Chem       Date:  2014-08-01       Impact factor: 5.157

8.  Siva1 inhibits p53 function by acting as an ARF E3 ubiquitin ligase.

Authors:  Xingwu Wang; Meng Zha; Xiaocheng Zhao; Peng Jiang; Wenjing Du; Andrew Y H Tam; Yide Mei; Mian Wu
Journal:  Nat Commun       Date:  2013       Impact factor: 14.919

9.  Regulation of GAD65 expression by SMAR1 and p53 upon Streptozotocin treatment.

Authors:  Sandeep Singh; Varsheish Raina; Pavithra Lakshminarsimhan Chavali; Taronish Dubash; Sreenath Kadreppa; Pradeep Parab; Samit Chattopadhyay
Journal:  BMC Mol Biol       Date:  2012-09-14       Impact factor: 2.946

10.  Preferential binding of hot spot mutant p53 proteins to supercoiled DNA in vitro and in cells.

Authors:  Marie Brázdová; Lucie Navrátilová; Vlastimil Tichý; Kateřina Němcová; Matej Lexa; Roman Hrstka; Petr Pečinka; Matej Adámik; Borivoj Vojtesek; Emil Paleček; Wolfgang Deppert; Miroslav Fojta
Journal:  PLoS One       Date:  2013-03-26       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.